Inspire Medical Systems, Inc. (NYSE:INSP) saw a 32.35% drop in stock price on Tuesday, closing at $87.91, due to disappointing Q2 earnings and a lower growth outlook. The company reported a net loss of $3.59 million, a significant decline from last year’s $9.8 million income, despite a 10.7% revenue increase to $217 million.

In the first half of the year, INSP widened its net loss by 183% to $600 million, while revenues grew by 16% to $418 million. CEO Tim Herbert remains optimistic, attributing operational challenges to temporary setbacks and implementing strategies to overcome them. The company now expects full-year revenues to range between $900 million and $910 million, lower than previous estimates of $940 million to $955 million.

Read more at Yahoo Finance: Inspire Medical (INSP) Takes 32% Nosedive on Dismal Earnings, Outlook